Evidence map›Paper›PMID 30717288›Full record

ArticleViruses2019

Twelfth International Foamy Virus Conference-Meeting Report.

Ottmar Herchenröder, Martin Löchelt, Florence Buseyne, Antoine Gessain, Marcelo A Soares, Arifa S Khan, Dirk Lindemann

Abstract readConference Proceedings
In one paragraph

Article in Viruses, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Review
  2. Article
  3. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Ottmar HerchenröderInstitut für Experimentelle Gentherapie und Tumorforschung, Universitätsmedizin Rostock, 18057 Rostock, Germany. ottmar.herchenroeder@med.uni-rostock.de.
Martin LöcheltDepartment of Viral Transformation Mechanisms, Research Program Infection, Inflammation and Cancer, 69120 Heidelberg, Germany. m.loechelt@dkfz.de.
Florence BuseyneUnité D'épidémiologie et Physiopathologie des Virus Oncogènes, Institut Pasteur, 75015 Paris, France. florence.buseyne@pasteur.fr.
Antoine GessainUnité D'épidémiologie et Physiopathologie des Virus Oncogènes, Institut Pasteur, 75015 Paris, France. antoine.gessain@pasteur.fr.
Marcelo A SoaresDepartamento de Genética, Universidade Federal do Rio de Janeiro, 21941-590 Rio de Janeiro, Brazil. masoares@inca.gov.br.
Arifa S KhanLaboratory of Retroviruses, Division of Viral Products, Center for Biologics Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, MD 20993, USA. arifa.khan@fda.hhs.gov.
Dirk LindemannInstitute of Virology, Medical Faculty "Carl Gustav Carus", Technische Universität Dresden, 01307 Dresden, Germany. dirk.lindemann@tu-dresden.de.

Funding

Deutsche Forschungsgemeinschaft Projektnummer 40694290TU Dresden's Institutional Strategy, funded by the Excellence Initiative of the German Federal and State Governments F-003661-533-Ü5D-1250000
6 · The paper itself

Abstract

The 12

Indexed as

Genetic TherapyRetroviridae InfectionsAnimalsGenetic VectorsGermanyHumansPrimatesResearchSpumavirusVirus Replicationcross-species virus transmissionfoamy virusFV vectorsimmune responseslatent infectionrestriction factorsspumaretrovirusvirus replicationzoonosis

Identifiers

PMID30717288
PMCPMC6409691

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.